Hudson 2003 Hudson SA, Tabet N
Despite this activity, GSPT1 degradation represents a promising potential therapeutic strategy, since GSPT1 dysregulation or increased expression is associated with multiple cancers
Rare neuropsychiatric effects including mood changes, suicidal ideation, and anxiety have been reported with GLP-1 medications
Furthermore, MD revealed decreased flexibility of p53 TAD2 in complex with FOXO4-DRI compared to the FOXO4 FH -bound state with RMSDs of 1 heteronuclear NOE data was recorded using the HSQCNOEF3GPSI bruker pulse sequence (32 scans, 256 points in F1, 1024 points in F2, 1278.772 Hz spectral width in F1, 9615.385 Hz spectral width in F2) using a three seconds saturation period
Start: 2 mg weekly for the first 4 weeks to settle tolerability [1] [4]